MEDICINAL CANNABIS MARKET ANALYSIS

Medicinal Cannabis Market, By Product Type (Flower, Concentrates, Edibles, Topicals & Transdermals, and Others ), By Compound (Tetrahydrocannabinol (THC) and Cannabidiol (CBD)), By Application (Cancer, Arthritis, Chronic Pain, Parkinson’s Disease, Epilepsy, and Others), By Distribution Channel (Hospital Pharmacies , Retail Pharmacies , Online Pharmacies), By Geography (North America, Europe, Asia Pacific, Latin America, Middle East and Africa).

Published In : Mar 2024
Code : CMI40
Pages :171
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Medicinal Cannabis Market Concentration, By Players

Close-monitor your Competitor's Move, Request sample copy

Aging Populations and Chronic Conditions

A confluence of demographic trends bodes well for the medical cannabis market. Advancements in modern medicine have lengthened lifespans worldwide, leading to more elderly populations with age-related health issues. Chronic conditions are becoming more prevalent include arthritis, cancer, and neurodegenerative diseases. Simultaneously, baby boomers born during the postwar period are entering their senior years in large numbers. This generation has proven more open to alternative treatments and active lifestyles later in life compared to previous cohorts. Younger patients are also living longer with conditions like epilepsy, multiple sclerosis, and cancer due to medical innovations - yet standard pharmaceuticals may lose effectiveness or cause intolerable side effects over decades of use. Research into non-addictive medications offers hope. The confluence of these societal trends implies wider acceptance and demand for cannabis as a therapeutic option, especially if its benefits for certain chronic conditions receive definitive scientific validation through ongoing clinical studies.

Key Players Insights